[Therapeutic procedure in chronic lymphadenosis (CLL)].
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000150:complications; D001803:Blood Transfusion; D002908:Chronic Disease; D005112:Extracorporeal Circulation; D006801:Humans; D006971:Hypersplenism / Q000150:complications; D007945:Leukemia, Lymphoid / Q000150:complications / Q000532:radiotherapy / Q000628:therapy*; D008722:Methods; D011879:Radiotherapy Dosage; D013156:Splenectomy; D013163:Splenomegaly / Q000150:complications
D000970:Antineoplastic Agents; D000324:Adrenocorticotropic Hormone
Therapeutisches Vorgehen bei chronischer Lymphadenose (CLL)